Lv0
0 积分 2026-02-12 加入
Avacopan for the Treatment of ANCA-Associated Vasculitis
23天前
已完结
Recent pathogenetic insights and therapeutic advances in ANCA-associated vasculitis
24天前
已完结
Advances in the treatment of ANCA-associated vasculitis
25天前
已完结
Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis
26天前
已完结
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
26天前
已完结
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
1个月前
已完结
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk
1个月前
已完结
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
1个月前
已完结
Managing Dyslipidemia in Chronic Kidney Disease: Implications for Cardiovascular and Renal Risk
1个月前
已完结
Lipid management in patients with chronic kidney disease
1个月前
已完结
皖公网安备34019202002308
